The Disappearing Arsenal of Antiparasitic Drugs

Publisher Website
Google Scholar
Abstract
Parasitic infections remain scourges to people worldwide.1 Increasing international travel and immigration from countries where parasitic infections are endemic ensure that clinicians in the United States will be required to treat patients with these infections. Although safe and inexpensive treatments are available for most of these infections,2 there are few incentives for the pharmaceutical industry to make these drugs available in the United States.

This publication has 3 references indexed in Scilit: